Contraception News and Research

Latest Contraception News and Research

One in ten primary care physicians in the U.S. experience conflict with religiously-affiliated hospital: Report

Nearly one in ten primary care physicians in the United States has experienced a conflict with a religiously-affiliated hospital or practice over religious policies for patient care, researchers from the University of Chicago report in a paper published early online in the Journal of General Internal Medicine.

9 Apr 2010

Data shows U.S. teen birth rate declined 2% in 2008

The nation's teen birth rate declined 2% in 2008, according to data released today by the Centers for Disease Control and Prevention's National Center for Health Statistics. After declining every year between 1991 and 2005, the teen birth rate increased 5% between 2005 and 2007 and is now on the decline again.

8 Apr 2010

Foreign Minister says Canada's G8 maternal, child health plan will not include abortion

At this summer's G8 meeting, Canadian Prime Minister Stephen Harper will move forward with his "'signature initiative' on maternal and children's health, despite disagreements with the United States and Britain over funding for abortion in the developing world, Foreign Minister Lawrence Cannon says," the Globe and Mail reports (McCarthy, 4/4).

6 Apr 2010

Fireside chat: BioSante's LibiGel and GVAX cancer vaccines portfolio

BioSante Pharmaceuticals, Inc. today announced that a BioSante presentation and corporate discussion are available at http://www.rodm.tv/video1269553400.

3 Apr 2010

UK NICE recommends Eli Lilly's ALIMTA as maintenance therapy for nonsquamous NSCLC

Eli Lilly and Company announced today that its chemotherapy ALIMTA® (pemetrexed for injection) received a positive "Final Appraisal Determination" from the United Kingdom's National Institute for Health and Clinical Excellence (NICE).

2 Apr 2010

Pro-Vas male contraceptive procedure available to physicians across the U.S.

Pro-Vas is the first male contraceptive procedure, other than condoms or vasectomy, to provide effective affordable birth control for men and it is available to physicians across the United States immediately.

1 Apr 2010

Family planning, access to safe, legal abortion key to maternal, child health, U.S. Sec. of State says

Following a two-day meeting of foreign ministers from G8 countries in Quebec on Tuesday, Secretary of State Hillary Rodham Clinton "appeared at odds … with [Canadian] Prime Minister Stephen Harper's G8 initiative on maternal and child health, saying family planning, contraception and access to legal, safe abortions were vital elements of maternal health care," Canwest News Service/Ottawa Citizen report (O'Neill, 3/31).

1 Apr 2010

BioSante Pharmaceuticals completes Azur Pharma Elestrin royalty buydown

BioSante Pharmaceuticals, Inc. today announced the successful completion of the Azur Pharma Elestrin royalty buydown, and financial results for the year ended December 31, 2009.

31 Mar 2010

Interim data comparing Cervista HPV HR to Hybrid Capture 2 presented at 4th Biennial Meeting of AOGIN

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced that interim data from the first large-scale independent evaluation of clinical performance of Cervista® HPV HR compared to Hybrid Capture 2 (hc2), were presented at the 4th Biennial Meeting of AOGIN (Asia-Oceanic Research Organization in Genital Infection and Neoplasia) in New Delhi, India on March 26-28, 2010.

29 Mar 2010

Backpacker problem in Australia - binge drinking and unprotected sex

The tourist season may not be quite as healthy for the locals as it was before. In an eight year old study conducted by the Sydney Sexual Health Care Centre some scary facts have come to light. The study was based on about 5,700 backpackers who belonged mostly to the UK or Ireland and were in their mid twenties.

28 Mar 2010

Invida to continue commercialization of Actelion's Tracleer for PAH in crucial Asian markets

Invida Group, the leading provider of healthcare brands and services to the Asia Pacific region, today announced that its contract with Swiss biotechnology company, Actelion, has been extended through 2015 to continue commercialization of Tracleer® for the treatment of pulmonary arterial hypertension (PAH) in crucial markets throughout Asia. Actelion signed with Invida initially in 2005, and has extended the contract to market the company’s lead product, Tracleer, in Thailand, Malaysia, Philippines, Vietnam, and Hong Kong

26 Mar 2010

BioSante Pharmaceuticals receives FDA Orphan Drug designation for GVAX AML Vaccine

BioSante Pharmaceuticals, Inc. today announced positive GVAX AML Vaccine results and BioSante’s receipt of Orphan Drug designation from the FDA’s Office of Orphan Products Development for GVAX AML Vaccine in the treatment of acute myeloid leukemia. This Orphan Drug designation is the second GVAX cancer vaccine from BioSante to secure FDA orphan drug designation.

23 Mar 2010

Gender divide over the healthcare reform bill

The historic healthcare reform bill has unearthed a strong difference between the Catholic nuns and Bishops. In short the great gender divide is at play again! While 59,000 nuns all over the country are in support of the bill, the U.S. Conference of Catholic Bishops oppose it strongly.

22 Mar 2010

Canadian Prime Minister says he's open to including contraception in G8 plan for improving maternal, child health

"Facing a squall of condemnation from aid groups and opposition politicians," following statements by Canadian Foreign Minister Lawrence Cannon that Canada's G8 maternal and child health initiative would not include family planning, Prime Minister Stephen Harper "disavowed his foreign minister Thursday, promising that the federal government would include contraception programs in its maternal-health foreign-aid initiative," the Globe and Mail reports.

20 Mar 2010

Advance provision of emergency contraception does not decrease pregnancy rates

Providing emergency contraception to women in advance of need does not reduce pregnancy rates, despite increased use and faster use after unprotected sexual intercourse. These are the findings according to a new review published in The Cochrane Library.

17 Mar 2010

Women on oral contraceptive pills live longer

Women who are taking or have taken the contraceptive pill in their lifetimes are not at an increased risk of death, Scottish researchers say. In fact, the pill may help to prolong life.

17 Mar 2010

BioSante Pharmaceuticals receives receipt of Orphan Drug designation for GVAX Pancreas Vaccine

BioSante Pharmaceuticals, Inc. today announced BioSante’s receipt of Orphan Drug designation from the FDA’s Office of Orphan Products Development for GVAX Pancreas Vaccine in the treatment of pancreatic cancer.

15 Mar 2010

BeaconEquity.com: BPAX incurs net loss of $6.4M for quarter ended September 30, 2009

BeaconEquity.com announces an investment report featuring biotechnology company BioSante Pharmaceuticals Inc. The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.

12 Mar 2010

New SpermCheck Fertility home test kit for sperm level measurement

Infertility affects between 10 and 15 percent of couples worldwide. Surprisingly, problems with male fertility account for approximately 50 percent of infertility cases.

12 Mar 2010

Positive results from BioSante Pharmaceuticals' GVAX Leukemia vaccine human clinical study

BioSante Pharmaceuticals, Inc. today announced positive results of a human clinical study that show that its GVAX Leukemia vaccine may be able to reduce or eliminate the last remaining cancer cells in some chronic myeloid leukemia (CML) patients taking the drug Gleevec (imatinib mesylate).

11 Mar 2010

Contraception News and Research

Latest Contraception News and Research

One in ten primary care physicians in the U.S. experience conflict with religiously-affiliated hospital: Report

Data shows U.S. teen birth rate declined 2% in 2008

Foreign Minister says Canada's G8 maternal, child health plan will not include abortion

Fireside chat: BioSante's LibiGel and GVAX cancer vaccines portfolio

UK NICE recommends Eli Lilly's ALIMTA as maintenance therapy for nonsquamous NSCLC

Pro-Vas male contraceptive procedure available to physicians across the U.S.

Family planning, access to safe, legal abortion key to maternal, child health, U.S. Sec. of State says

BioSante Pharmaceuticals completes Azur Pharma Elestrin royalty buydown

Interim data comparing Cervista HPV HR to Hybrid Capture 2 presented at 4th Biennial Meeting of AOGIN

Backpacker problem in Australia - binge drinking and unprotected sex

Invida to continue commercialization of Actelion's Tracleer for PAH in crucial Asian markets

BioSante Pharmaceuticals receives FDA Orphan Drug designation for GVAX AML Vaccine

Gender divide over the healthcare reform bill

Canadian Prime Minister says he's open to including contraception in G8 plan for improving maternal, child health

Advance provision of emergency contraception does not decrease pregnancy rates

Women on oral contraceptive pills live longer

BioSante Pharmaceuticals receives receipt of Orphan Drug designation for GVAX Pancreas Vaccine

BeaconEquity.com: BPAX incurs net loss of $6.4M for quarter ended September 30, 2009

New SpermCheck Fertility home test kit for sperm level measurement

Positive results from BioSante Pharmaceuticals' GVAX Leukemia vaccine human clinical study

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Contraception News and Research

Latest Contraception News and Research

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Newsletters you may be interested in